Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

Question 2

How does trastuzumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or procedures I would need to undergo before starting the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells clinical trial (NCT01779050). Contact the study team or your healthcare provider for specific answers.

What this study is about